Vascular endothelial growth factor receptor-3 activity is modulated by its association with caveolin-1 on endothelial membrane

Biochemistry

Volumn 46, Issue 13, 2007, Pages 3998-4005

  Galvagni, Federico ^a   Anselmi, Francesca ^a   Salameh, Ahmad ^a   Orlandini, Maurizio ^a   Rocchigiani, Marina ^a   Oliviero, Salvatore ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD VESSELS; CELLS; CHOLESTEROL; PHOSPHORYLATION; PRECIPITATES; PROTEINS;

ANGIOGENESIS; ENDOTHELIAL GROWTH FACTOR; ENDOTHELIAL MEMBRANE; IMMUNOPRECIPITATES;

CELL MEMBRANES;

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ABELSON KINASE; CAVEOLIN 1; IMATINIB; PROTEIN KINASE FYN; PROTEIN KINASE YES; PROTEIN TYROSINE KINASE; TYROSINE; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; CAVEOLA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CAVEOLAE; CAVEOLIN 1; CELL MEMBRANE; CLONE CELLS; ENDOTHELIUM, VASCULAR; HUMANS; LYMPHOID TISSUE; MICE; PHOSPHORYLATION; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS PP60(C-SRC); PYRIMIDINES; SUS SCROFA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 34047213486     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi061400n     Document Type: Article

References (49)

1. Carmeliet, P. (2003) Angiogenesis in health and disease, Nat. Med. 9, 653-660.
2. Ferrara, N., Gerber, H. P., and LeCouter, J. (2003) The biology of VEGF and its receptors, Nat. Med. 9, 669-676.
3. Tammela, T., Petrova, T. V., and Alitalo, K. (2005) Molecular lymphangiogenesis: new players, Trends Cell Biol. 15, 434-441.
4. Dumont, D. J., Jussila, L., Taipale, J., Lymboussaki, A., Mustonen, T., Pajusola, K., Breitman, M., and Alitalo, K. (1998) Cardiovascular failure in mouse embryos deficient in VEGF receptor-3, Science 282, 946-949.
5. Veikkola, T., Jussila, L., Makinen, T., Karpanen, T., Jeltsch, M., Petrova, T. V., Kubo, H., Thurston, G., McDonald, D. M., Achen, M. G., Stacker, S. A., and Alitalo, K. (2001) Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice, EMBO J. 20, 1223-1231.
6. Makinen, T., Jussila, L., Veikkola, T., Karpanen, T., Kettunen, M. I., Pulkkanen, K. J., Kauppinen, R., Jackson, D. G., Kubo, H., Nishikawa, S., Yla-Herttuala, S., and Alitalo, K. (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3, Nat. Med. 7, 199-205.
7. Partanen, T. A., Arola, J., Saaristo, A., Jussila, L., Ora, A., Miettinen, M., Stacker, S. A., Achen, M. G., and Alitalo, K. (2000) VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues, FASEB J. 14, 2087-2096.
8. Witmer, A. N., van Blijswijk, B. C., Dai, J., Hofman, P., Partanen, T. A., Vrensen, G. F., and Schlingemann, R. O. (2001) VEGFR-3 in adult angiogenesis, J. Pathol. 195, 490-497.
9. Witmer, A. N., Dai, J., Weich, H. A., Vrensen, G. F., and Schlingemann, R. O. (2002) Expression of vascular endothelial growth factor receptors 1, 2, and 3 in quiescent endothelia, J. Histochem. Cytochem. 50, 767-777.
10. Partanen, T. A., Alitalo, K., and Miettinen, M. (1999) Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors, Cancer 86, 2406-2412.
11. Valtola, R., Salven, P., Heikkila, P., Taipale, J., Joensuu, H., Rehn, M., Pihlajaniemi, T., Weich, H., deWaal, R., and Alitalo, K. (1999) VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer, Am. J. Pathol. 154, 1381-1390.
12. Kubo, H., Fujiwara, T., Jussila, L., Hashi, H., Ogawa, M., Shimizu, K., Awane, M., Sakai, Y., Takabayashi, A., Alitalo, K., Yamaoka, Y., and Nishikawa, S. I. (2000) Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis, Blood 96, 546-553.
13. Achen, M. G., Williams, R. A., Baldwin, M. E., Lai, P., Roufail, S., Alitalo, K., and Stacker, S. A. (2002) The angiogenic and lymphangiogenic factor vascular endothelial growth factor-D exhibits a paracrine mode of action in cancer, Growth Factors 20, 99-107.
14. Matsumura, K., Hirashima, M., Ogawa, M., Kubo, H., Hisatsune, H., Kondo, N., Nishikawa, S., and Chiba, T. (2003) Modulation of VEGFR-2-mediated endothelial-cell activity by VEGF-C/VEGFR-3, Blood 101, 1367-1374.
15. Salameh, A., Galvagni, F., Bardelli, M., Bussolino, P., and Oliviero, S. (2005) Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways, Blood 106, 3423-3431.
16. Dixelius, J., Makinen, T., Wirzenius, M., Karkkainen, M. J., Wernstedt, C., Alitalo, K., and Claesson-Welsh, L. (2003) Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites, J. Biol. Chem. 278, 40973-40979.
17. Feng, Y., Venema, V. J., Venema, R. C., Tsai, N., Behzadian, M. A., and Caldwell, R. B. (1999) VEGF-induced permeability increase is mediated by caveolae, Invest. Ophthalmol. Visual Sci. 40, 157-167.
18. Labrecque, L., Royal, I., Surprenant, D. S., Patterson, C., Gingras, D., and Beliveau, R. (2003) Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol, Mol. Biol. Cell 14, 334-347.
19. Stan, R. V. (2005) Structure of caveolae, Biochim. Biophys. Acta 1746, 334-348.
20. Lisanti, M. P., Scherer, P. E., Vidugiriene, J., Tang, Z., Hermanowski-Vosatka, A., Tu, Y. H., Cook, R. F., and Sargiacomo, M. (1994) Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease, J. Cell Biol. 126, 111-126.
21. Schubert, W., Frank, P. G., Razani, B., Park, D. S., Chow, C. W., and Lisanti, M. P. (2001) Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo, J. Biol. Chem. 276, 48619-48622.
22. Scherer, P. E., Tang, Z., Chun, M., Sargiacomo, M., Lodish, H. F., and Lisanti, M. P. (1995) Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-speciflc monoclonal antibody probe, J. Biol. Chem. 270, 16395-16401.
23. Gratton, J. P., Bernatchez, P., and Sessa, W. C. (2004) Caveolae and caveolins in the cardiovascular system, Circ. Res. 94, 1408-1417.
24. Griffoni, C., Spisni, E., Santi, S., Riccio, M., Guarnieri, T., and Tomasi, V. (2000) Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo, Biochem. Biophys. Res. Commun. 276, 756-761.
25. Liu, J., Razani, B., Tang, S., Terman, B. I., Ware, J. A., and Lisanti, M. P. (1999) Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1, J. Biol. Chem. 274, 15781-15785.
26. Liu, J., Wang, X. B., Park, D. S., and Lisanti, M. P. (2002) Caveolin-1 expression enhances endothelial capillary tubule formation, J. Biol. Chem. 277, 10661-10668.
27. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., Schedl, A., Haller, H., and Kurzchalia, T. V. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice, Science 293, 2449-2452.
28. Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., Di Vizio, D., Hou, H., Jr., Kneitz, B., Lagaud, G., Christ, G. L., Edelmann, W., and Lisanti, M. P. (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities, J. Biol. Chem. 276, 38121-38138.
29. Krajewska, W. M., and Maslowska, I. (2004) Caveolins: structure and function in signal transduction, Cell Mol. Biol. Lett. 9, 195-220.
30. Smart, E. J., Graf, G. A., McNiven, M. A., Sessa, W. C., Engelman, J. A., Scherer, P. E., Okamoto, T., and Lisanti, M. P. (1999) Caveolins, liquid-ordered domains, and signal transduction, Mol. Cell. Biol. 19, 7289-7304.
31. Furuchi, T., and Anderson, R. G. (1998) Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK), J. Biol. Chem. 273, 21099-21104.
32. Chen, X., and Resh, M. D. (2002) Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor, J. Biol. Chem. 277, 49631-49637.
33. Barila, D., and Superti-Furga, G. (1998) An intramolecular SH3-domain interaction regulates c-Abl activity, Nat. Genet. 18, 280-282.
34. Barila, D., Rufini, A., Condo, I., Ventura, N., Dorey, K., Superti-Furga, G., and Testi, R. (2003) Caspase-dependent cleavage of c-Abl contributes to apoptosis, Mol. Cell. Biol. 23, 2790-2799.
35. Smart, E. J., Ying, Y. S., Mineo, C., and Anderson, R. G. (1995) A detergent-free method for purifying caveolae membrane from tissue culture cells, Proc. Natl. Acad. Sci. U.S.A. 92, 10104-10108.
36. Marconcini, L., Marchiò, S., Morbidelli, L., Cartocci, E., Albini, A., Ziche, M., Bussolino, F., and Oliviero, S. (1999) c-fos-induced growth factor/vascular endothelial growth factor-D induces angiogenesis in vivo and in vitro, Proc. Natl. Acad. Sci. U.S.A. 96, 9671-9676.
37. Li, S., Seitz, R., and Lisanti, M. P. (1996) Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo, J. Biol. Chem. 271, 3863-3868.
38. Cao, H., Courchesne, W. E., and Mastick, C. C. (2002) A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase, J. Biol. Chem. 277, 8771-8774.
39. Kim, Y. N., Wiepz, G. J., Guadarrama, A. G., and Bertics, P. J. (2000) Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status, J. Biol. Chem. 275, 7481-7491.
40. Glenney, J. R., Jr., and Zokas, L. (1989) Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton, J. Cell Biol. 108, 2401-2408.
41. Glenney, J. R., Jr. (1989) Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus, J. Biol. Chem. 264, 20163-20166.
42. Corley Mastick, C., Sanguinetti, A. R., Knesek, J. H., Mastick, G. S., and Newcomb, L. F. (2001) Caveolin-1 and a 29-kDa caveolin-associated protein are phosphorylated on tyrosine in cells expressing a temperature-sensitive v-Ab1 kinase, Exp. Cell Res. 266, 142-154.
43. Sanguinetti, A. R., and Mastick, C. C. (2003) c-Ab1 is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14, Cell. Signalling 15, 289-298.
44. Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., and Connelly, P. A. (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation, J. Biol. Chem. 271, 695-701.
45. Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., and Lydon, N. B. (1996) Effects of a selective inhibitor of the Ab1 tyrosine kinase on the growth of Bcr-Ab1 positive cells, Nat. Med. 2, 561-566.
46. Klinghoffer, R. A., Sachsenmaier, C., Cooper, J. A., and Soriano, P. (1999) Src family kinases are required for integrin but not PDGFR signal transduction, EMBO J. 18, 2459-2471.
47. Couet, J., Sargiacomo, M., and Lisanti, M. P. (1997) Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities, J. Biol. Chem. 272, 30429-30438.
48. Lee, H., Volonte, D., Galbiati, F., Iyengar, P., Lublin, D. M., Bregman, D. B., Wilson, M. T., Campos-Gonzalez, R., Bouzahzah, B., Pestell, R. G., Scherer, P. E., and Lisanti, M. P. (2000) Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette, Mol. Endocrinol. 14, 1750-1775.
49. del Pozo, M. A., Balasubramanian, N., Alderson, N. B., Kiosses, W. B., Grande-Garcia, A., Anderson, R. G., and Schwartz, M. A. (2005) Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization, Nat. Cell Biol. 7, 901-908.